Lactobacillus strains induce TRAIL production and facilitate natural killer activity against cancer cells

被引:32
作者
Horinaka, Mano [1 ]
Yoshida, Tatsushi [1 ]
Kishi, Atsuko [2 ]
Akatani, Kaoru [2 ]
Yasuda, Takashi [1 ,3 ]
Kouhara, Junji [1 ,4 ]
Wakada, Miki [1 ]
Sakai, Toshiyuki [1 ]
机构
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kamigyo Ku, Kyoto 6028566, Japan
[2] Louis Pasteur Ctr Med Res, Sakyo Ku, Kyoto 6068225, Japan
[3] Kyoto Prefectural Univ Med, Dept Urol, Kamigyo Ku, Kyoto 6028566, Japan
[4] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Digest Surg, Kamigyo Ku, Kyoto 6028566, Japan
关键词
TRAIL; Cancer; Natural killer activity; Lactobacillus; PLANTARUM L-137; LIGAND TRAIL; APOPTOSIS; CASEI; CARCINOGENESIS; NEUTROPHILS; TRIAL; GENE; MICE;
D O I
10.1016/j.febslet.2009.12.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an endogenous cytokine that induces apoptosis in malignant tumor cells. Here, we show for the first time that lactobacilli induce TRAIL production in human peripheral blood mononuclear cells (PBMC). Treatment with lactobacilli induced TRAIL on the cell surface of PBMC and in culture medium. The TRAIL production induced by lactobacilli partially depends on IFN-alpha and IFN-gamma. Lactobacilli treatment facilitated NK activity of PBMC against prostate cancer cells. Moreover, TRAIL neutralization antibody efficiently prevented the NK activity. Our results indicate that lactobacilli facilitate NK activity through TRAIL production, and raise the possibility of a new TRAIL-based strategy against malignant tumors. (C) 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:577 / 582
页数:6
相关论文
共 24 条
[1]   Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[2]   To kill a tumor cell: the potential of proapoptotic receptor agonists [J].
Ashkenazi, Avi ;
Herbst, Roy S. .
JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (06) :1979-1990
[3]   PREVENTIVE EFFECT OF A LACTOBACILLUS-CASEI PREPARATION ON THE RECURRENCE OF SUPERFICIAL BLADDER-CANCER IN A DOUBLE-BLIND TRIAL [J].
ASO, Y ;
AKAZA, H ;
KOTAKE, T ;
TSUKAMOTO, T ;
IMAI, K ;
NAITO, S .
EUROPEAN UROLOGY, 1995, 27 (02) :104-109
[4]   Effects of milk fermented by Lactobacillus helveticus R389 on a murine breast cancer model [J].
de LeBlanc, AD ;
Matar, C ;
LeBlanc, N ;
Perdigón, G .
BREAST CANCER RESEARCH, 2005, 7 (04) :R477-R486
[5]   Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling [J].
El-Deiry, WS .
CELL DEATH AND DIFFERENTIATION, 2001, 8 (11) :1066-1075
[6]   Genomic organization and transcriptional regulation of human Apo2/TRAIL gene [J].
Gong, B ;
Almasan, A .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 278 (03) :747-752
[7]   Daily intake of heat-killed Lactobacillus plantarum L-137 augments acquired immunity in healthy adults [J].
Hirose, Yoshitaka ;
Murosaki, Shinji ;
Yamamoto, Yoshihiro ;
Yoshikai, Yasunobu ;
Tsuru, Tomomi .
JOURNAL OF NUTRITION, 2006, 136 (12) :3069-3073
[8]   The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligand [J].
Horinaka, M ;
Yoshida, T ;
Shiraishi, T ;
Nakata, S ;
Wakada, M ;
Sakai, T .
MOLECULAR CANCER THERAPEUTICS, 2006, 5 (04) :945-951
[9]   The combination of TRAIL and luteolin enhances apoptosis in human cervical cancer HeLa cells [J].
Horinaka, M ;
Yoshida, T ;
Shiraishi, T ;
Nakata, S ;
Wakada, M ;
Nakanishi, R ;
Nishino, H ;
Sakai, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 333 (03) :833-838
[10]   Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors [J].
Ishikawa, H ;
Akedo, I ;
Otani, T ;
Suzuki, T ;
Nakamura, T ;
Takeyama, I ;
Ishiguro, S ;
Miyaoka, E ;
Sobue, T ;
Kakizoe, T .
INTERNATIONAL JOURNAL OF CANCER, 2005, 116 (05) :762-767